Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells
- PMID: 12167346
- DOI: 10.1006/viro.2002.1457
Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells
Abstract
Epstein-Barr virus (EBV) encodes multiple latency programs: a growth-transforming program (type III) latency program and restricted-latency (types I and II) programs. During type III latency, EBV expresses six nuclear antigens, all of which are encoded by a single complex transcriptional unit driven by two linked promoters, Cp and Wp, while restricted viral latency is characterized by the expression of a single nuclear antigen, EBNA1, whose expression is driven from a distinct transcription unit under the control of the Qp promoter. EBV infection of the 293 epithelial cell line frequently leads to the establishment of a type I/II latent infection. Here we report that during the initial stages of virus infection of the 293 cell line, both Cp and Wp are active. However, analysis of four established, low-passage EBV-infected 293 cell lines revealed that three of these exhibited Qp-driven transcription of the EBNA 1 gene and little or no detectable Cp and Wp activity, while the fourth cell line exhibited Cp activity. Notably, all four cell lines contained the necessary transcription factors to drive transcription initiation from Cp and Wp when transiently transfected with unmethylated reporter constructs. Furthermore, in the cell lines exhibiting restricted EBV latency the viral genomes were extensively methylated around Cp and Wp, but not Qp. In contrast, in the cell line exhibiting Cp activity the viral genomes were hypomethylated around Cp, Wp, and Qp. Taken together, these results provide evidence that the establishment of a restricted latent infection in the 293 epithelial cell line is not due to a failure to initiate the growth-transforming (type III) latency program, but rather may arise from a selection against the type III latency program. Furthermore, these results are consistent with the hypothesis that methylation of Cp and Wp is required for entry into the type I or II latency programs.
Similar articles
-
Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.J Med Virol. 2003 Jul;70(3):410-9. doi: 10.1002/jmv.10411. J Med Virol. 2003. PMID: 12767005
-
Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.J Gen Virol. 2003 May;84(Pt 5):1133-1140. doi: 10.1099/vir.0.18777-0. J Gen Virol. 2003. PMID: 12692278
-
High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.Virus Genes. 2007 Oct;35(2):195-202. doi: 10.1007/s11262-007-0095-y. Epub 2007 May 18. Virus Genes. 2007. PMID: 17510783
-
Epigenetic regulation of latent Epstein-Barr virus promoters.Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):228-35. doi: 10.1016/j.bbagrm.2009.10.005. Epub 2009 Oct 22. Biochim Biophys Acta. 2010. PMID: 19853674 Review.
-
Epigenotypes of latent herpesvirus genomes.Curr Top Microbiol Immunol. 2006;310:61-80. doi: 10.1007/3-540-31181-5_5. Curr Top Microbiol Immunol. 2006. PMID: 16909907 Review.
Cited by
-
Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA.J Virol. 2014 May;88(10):5474-90. doi: 10.1128/JVI.03110-13. Epub 2014 Feb 26. J Virol. 2014. PMID: 24574412 Free PMC article.
-
The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases.Appl Microbiol Biotechnol. 2022 Jun;106(12):4413-4426. doi: 10.1007/s00253-022-12029-3. Epub 2022 Jun 28. Appl Microbiol Biotechnol. 2022. PMID: 35763069 Free PMC article. Review.
-
Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.J Virol. 2016 Dec 16;91(1):e01434-16. doi: 10.1128/JVI.01434-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795414 Free PMC article.
-
The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.J Virol. 2010 May;84(10):4946-59. doi: 10.1128/JVI.00060-10. Epub 2010 Mar 3. J Virol. 2010. PMID: 20200245 Free PMC article.
-
Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication.J Virol. 2003 May;77(10):5731-9. doi: 10.1128/jvi.77.10.5731-5739.2003. J Virol. 2003. PMID: 12719566 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous